Library-based display technologies: where do we stand?

Over the past two decades, library-based display technologies have been staggeringly optimized since their appearance in order to mimic the process of natural molecular evolution. Display technologies are essential for the isolation of specific high-affinity binding molecules (proteins, polypeptides, nucleic acids and others) for diagnostic and therapeutic applications in cancer, infectious diseases, autoimmune, neurodegenerative, inflammatory pathologies etc. Applications extend to other fields such as antibody and enzyme engineering, cell-free protein synthesis and the discovery of protein-protein interactions. Phage display technology is the most established of these methods but more recent fully in vitro alternatives, such as ribosome display, mRNA display, cis-activity based (CIS) display and covalent antibody display (CAD), as well as aptamer display and in vitro compartmentalization, offer advantages over phage in library size, speed and the display of unnatural amino acids and nucleotides. Altogether, they have produced several molecules currently approved or in diverse stages of clinical or preclinical testing and have provided researchers with tools to address some of the disadvantages of peptides and nucleotides such as their low affinity, low stability, high immunogenicity and difficulty to cross membranes. In this review we assess the fundamental technological features and point out some recent advances and applications of display technologies.

[1]  Damian Labuda,et al.  In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. , 2004, Biochemical and biophysical research communications.

[2]  Harold G. Craighead,et al.  High-throughput binding characterization of RNA aptamer selections using a microplate-based multiplex microcolumn device , 2014, Analytical and Bioanalytical Chemistry.

[3]  M. Bhide,et al.  A rapid and simple pipeline for synthesis of mRNA-ribosome-V(H)H complexes used in single-domain antibody ribosome display. , 2015, Molecular bioSystems.

[4]  D. M. Brown,et al.  An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. , 1996, Journal of molecular biology.

[5]  M. Famulok,et al.  Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a microbalance array and mass spectrometry (MAMS). , 2009, Journal of proteome research.

[6]  M. Metzker Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[7]  Lee Makowski,et al.  T7 lytic phage‐displayed peptide libraries exhibit less sequence bias than M13 filamentous phage‐displayed peptide libraries , 2006, Proteomics.

[8]  Andrew D Ellington,et al.  In vitro selection of molecular beacons. , 2003, Nucleic acids research.

[9]  J. E. Stacy,et al.  Covalent antibody display—an in vitro antibody-DNA library selection system , 2005, Nucleic acids research.

[10]  N. Nemoto,et al.  Increasing the library size in cDNA display by optimizing purification procedures , 2013, Biological Procedures Online.

[11]  S. Cutting,et al.  Bacillus subtilis spores expressing the VP28 antigen: a potential oral treatment to protect Litopenaeus vannamei against white spot syndrome. , 2014, FEMS microbiology letters.

[12]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[13]  Monica H Lamm,et al.  Computational and experimental analyses converge to reveal a coherent yet malleable aptamer structure that controls chemical reactivity. , 2009, Journal of the American Chemical Society.

[14]  M. Taussig,et al.  Eukaryotic ribosome display with in situ DNA recovery , 2007, Nature Methods.

[15]  Xiang-Qian Peng,et al.  Improved Thermostability of Lipase B from Candida antarctica by Directed Evolution and Display on Yeast Surface , 2012, Applied Biochemistry and Biotechnology.

[16]  S. Hong,et al.  Construction of a high efficiency copper adsorption bacterial system via peptide display and its application on copper dye polluted wastewater , 2015, Bioprocess and Biosystems Engineering.

[17]  Aihua Liu,et al.  Simultaneously improving stability and specificity of cell surface displayed glucose dehydrogenase mutants to construct whole-cell biocatalyst for glucose biosensor application. , 2013, Bioresource technology.

[18]  Hiroshi Murakami,et al.  Ribosomal synthesis of peptidase-resistant peptides closed by a nonreducible inter-side-chain bond. , 2008, ACS chemical biology.

[19]  V. Petrenko,et al.  Phagemid vectors for phage display: properties, characteristics and construction. , 2012, Journal of molecular biology.

[20]  S. Muyldermans,et al.  Naturally occurring antibodies devoid of light chains , 1993, Nature.

[21]  H R Hoogenboom,et al.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.

[22]  Richard W Roberts,et al.  In vitro selection of protein and peptide libraries using mRNA display. , 2009, Methods in molecular biology.

[23]  Marco G. Casteleijn,et al.  Expression without boundaries: cell-free protein synthesis in pharmaceutical research. , 2013, International journal of pharmaceutics.

[24]  K D Wittrup,et al.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Sergey N Krylov,et al.  Non-SELEX: selection of aptamers without intermediate amplification of candidate oligonucleotides , 2006, Nature Protocols.

[26]  K. Leong,et al.  Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation. , 2015, ACS nano.

[27]  Anthony D. Keefe,et al.  Aptamers as therapeutics , 2010, Nature Reviews Drug Discovery.

[28]  S. Dübel,et al.  Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. , 2010, Veterinary microbiology.

[29]  L. Gold,et al.  Post-SELEX combinatorial optimization of aptamers. , 1997, Bioorganic & medicinal chemistry.

[30]  Jan Berka,et al.  Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencing. , 2015, Journal of molecular biology.

[31]  V. Choumet,et al.  A novel strategy for the functional cloning of enzymes using filamentous phage display: the case of nucleotidyl transferases. , 2002, Nucleic acids research.

[32]  A. Spirin,et al.  Enzymatic activity of the ribosome‐bound nascent polypeptide , 1996, FEBS letters.

[33]  J. Hillebrecht,et al.  A comparative study of protein synthesis in in vitro systems: from the prokaryotic reconstituted to the eukaryotic extract-based , 2008, BMC biotechnology.

[34]  T. Sawasaki,et al.  Efficient synthesis of a disulfide-containing protein through a batch cell-free system from wheat germ. , 2003, European Journal of Biochemistry.

[35]  Dirk Ponsel,et al.  High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation , 2011, Molecules.

[36]  M. Obuchowski,et al.  A system of vectors for Bacillus subtilis spore surface display , 2014, Microbial Cell Factories.

[37]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Power,et al.  A new generation of protein display scaffolds for molecular recognition , 2006, Protein science : a publication of the Protein Society.

[39]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[40]  P. Krieg,et al.  Ribosome inactivation by ricin A chain: a sensitive method to assess the activity of wild‐type and mutant polypeptides. , 1989, The EMBO journal.

[41]  E. P. Hudson,et al.  Multiplex epitope mapping using bacterial surface display reveals both linear and conformational epitopes , 2012, Scientific Reports.

[42]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[43]  Babak Bakhshinejad,et al.  Phage display: development of nanocarriers for targeted drug delivery to the brain , 2015, Neural regeneration research.

[44]  S. Sidhu,et al.  Phage display for selection of novel binding peptides. , 2000, Methods in enzymology.

[45]  Larry Gold,et al.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.

[46]  W. Stemmer Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.

[47]  A. Plückthun,et al.  Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. , 1999, Journal of immunological methods.

[48]  J. Bruno A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches , 2013, Pharmaceuticals.

[49]  A. Radbruch,et al.  Small but mighty: How the MACS®‐technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[50]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[51]  A. Kouzani,et al.  Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine , 2015, Theranostics.

[52]  E. Beghetto,et al.  Antigen discovery using whole-genome phage display libraries. , 2013, Methods in molecular biology.

[53]  D. Coomber,et al.  CIS display: In vitro selection of peptides from libraries of protein-DNA complexes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Mourez,et al.  Surface display of proteins by Gram-negative bacterial autotransporters , 2006, Microbial cell factories.

[55]  Y. Zu,et al.  Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.

[56]  Y. Omidi,et al.  Nanoscaled aptasensors for multi-analyte sensing , 2014, BioImpacts : BI.

[57]  D. Missiakas,et al.  Protein secretion and surface display in Gram-positive bacteria , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[58]  C. Ban,et al.  A coordination polymer nanobelt (CPNB)-based aptasensor for sulfadimethoxine. , 2012, Biosensors & bioelectronics.

[59]  C. Amemiya,et al.  Distinct patterns of IgH structure and organization in a divergent lineage of chrondrichthyan fishes , 1998, Immunogenetics.

[60]  P. DasSarma,et al.  Gas Vesicle Nanoparticles for Antigen Display , 2015, Vaccines.

[61]  M. Rajabibazl,et al.  A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis , 2013, Biotechnology Letters.

[62]  F. Hollfelder,et al.  SNAP display: in vitro protein evolution in microdroplets. , 2012, Methods in molecular biology.

[63]  U. Dietrich,et al.  Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library , 2013, European journal of immunology.

[64]  Sang Yup Lee,et al.  Microbial cell-surface display. , 2003, Trends in biotechnology.

[65]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[66]  R. Roberts,et al.  Serum Stable Natural Peptides Designed by mRNA Display , 2014, Scientific Reports.

[67]  Jennifer A. Getz,et al.  A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry , 2013, PloS one.

[68]  P. Pavlík,et al.  Eliminating helper phage from phage display , 2006, Nucleic acids research.

[69]  M. Ueda,et al.  Cell wall structure suitable for surface display of proteins in Saccharomyces cerevisiae , 2014, Yeast.

[70]  H. Binz,et al.  Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications , 2012, Angiogenesis.

[71]  Jae-Gu Pan,et al.  Bacillus spore display. , 2012, Trends in biotechnology.

[72]  John McCafferty,et al.  Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.

[73]  R. Minter,et al.  Probing a protein–protein interaction by in vitro evolution , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Jung,et al.  Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics. , 2014, Current opinion in biotechnology.

[75]  J. Douthwaite,et al.  Highly efficient ribosome display selection by use of purified components for in vitro translation. , 2006, Journal of immunological methods.

[76]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  W. Marsden I and J , 2012 .

[78]  Min Li Applications of display technology in protein analysis , 2000, Nature Biotechnology.

[79]  Y. Zhen,et al.  Targeting TNF-α with a tetravalent mini-antibody TNF-TeAb , 2007 .

[80]  R. Cooley,et al.  An in vitro selection strategy for conferring protease resistance to ligand binding peptides. , 2009, Protein engineering, design & selection : PEDS.

[81]  S. Dübel,et al.  Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo , 2012, PloS one.

[82]  H R Hoogenboom,et al.  Antibody phage display technology and its applications. , 1998, Immunotechnology : an international journal of immunological engineering.

[83]  Richard W Roberts,et al.  mRNA display: ligand discovery, interaction analysis and beyond. , 2003, Trends in biochemical sciences.

[84]  H. Hoogenboom,et al.  Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.

[85]  M. Glassy,et al.  Antibody phage display: overview of a powerful technology that has quickly translated to the clinic. , 2009, Methods in molecular biology.

[86]  Seung Soo Oh,et al.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.

[87]  Courtney C Aldrich,et al.  Engineering the substrate specificity of the DhbE adenylation domain by yeast cell surface display. , 2013, Chemistry & biology.

[88]  Serge Muyldermans,et al.  Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.

[89]  Ying-ying Lin,et al.  Antigen 43/Fcε3 chimeric protein expressed by a novel bacterial surface expression system as an effective asthma vaccine , 2014, Immunology.

[90]  C. Eigenbrot,et al.  High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. , 2004, Journal of molecular biology.

[91]  G. Rozenblum,et al.  Aptamers: current challenges and future prospects , 2016, Expert opinion on drug discovery.

[92]  J. Devlin,et al.  Random peptide libraries: a source of specific protein binding molecules. , 1990, Science.

[93]  Mark A Behlke,et al.  In vivo SELEX for Identification of Brain-penetrating Aptamers , 2013, Molecular therapy. Nucleic acids.

[94]  R. Stevens,et al.  Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin , 2007, Nature Biotechnology.

[95]  Hui Lin,et al.  Microfluidic approaches to rapid and efficient aptamer selection. , 2014, Biomicrofluidics.

[96]  W. Duan,et al.  Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. , 2013, Analytical chemistry.

[97]  J W Szostak,et al.  RNA-peptide fusions for the in vitro selection of peptides and proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.